The Role of Cytokines as Inflammatory Mediators in Osteoarthritis: Lessons from Animal Models

References

• Mankin H. J. Clinical features of osteoarthritis. Textbook of Rheumatology, W. N. Kelley, E. D.J. Harris, S. Ruddy, C. B. Sledge. WB Saunders, Philadelphia 1989; 1480–1500
   Google Scholar
• Goldberg V. The immunology of articular cartilage. Osteoarthritis Diagnosis and Management, R. W. Moskowitz, D. S. Howell, V. M. Goldberg, H. J. Mankin. W.B. Saunders Co, Philadelphia 1984; 81–92
   Google Scholar
• Denko C. Osteoarthritis: a metabolic disorder. New Developments in Antirheumatic Therapy, K. D. Rainsford, G. P. Velo. Academic Publishers, Kluwer. 1989; 29–35
   Google Scholar
• Moskowitz R. Experimental models of osteoarthritis. Osteoarthritis, Diagnosis and Management, R. W. Moskowitz, D. S. Howell, V. M. Goldberg, H. J. Mankin. W.B. Saunders, Philadelphia 1992; 213–232
   Google Scholar
• Greenwald R. A., Diamond H. CRC Handbook of Animals for the Rheumatic Diseases. CRC Press, Inc, Boca Raton, FL 1988; 214
   Google Scholar
• Ghosh P., Armstrong S., Read R., Numata Y., Smith S., Nair P., Marshall R. Animal models of early osteoarthritis: their use for the evaluation of potential chondroprotective agents. Agents and Actions - Supplements 1993; 39: 195–206
   PubMedGoogle Scholar
• Pritzker K. Animal models for osteoarthritis: processes, problems and prospects. Ann. Rheum. Dis. 1994; 53: 406–420
   PubMed Web of Science ®Google Scholar
• Brandt K. Insights into the natural history of osteoarthritis provided by the cruciate-deficient dog. An animal model of osteoarthritis. Annals of the New York Academy of Sciences 1994; 732: 199–205
   PubMed Web of Science ®Google Scholar
• Malemud C. Markers of osteoarthritis and cartilage research in animal models. Curr. Opin. Rheumatol. 1993; 5: 494–502
   PubMedGoogle Scholar
• Kalden J. Biologic agents in the therapy of inflammatory rheumatic diseases, including therapeutic antibodies, cytokines, and cytokine antagonists. Curr. Opin. Rheumatol 1994; 6: 281–286
   PubMedGoogle Scholar
• Kang R., Ghivizzani S., Herndon J. H., Robbins P. D., Evans C. H. Gene therapy for arthritis: principles and clinical practice. Biochem. Soc. Trans. 1997; 25: 533–537
   PubMed Web of Science ®Google Scholar
• Lark M., Bayne E. K., Flanagan J., Harper C. F., Hoerrner L. A., Hutchinson N. I., Donatelli S. A., Williams H. R., Mumford R., Lohmander L. S. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J. Clin. Invest. 1997; 100: 93–106
   PubMed Web of Science ®Google Scholar
• van denBerg W. Lessons for joint destruction from animal models. Curr. Opin. Rheumatol. 1997; 9: 221–228
   PubMedGoogle Scholar
• Goldring M. Degradation of articular cartilage in culture: Regulatory factors. Joint Cartilage Degradation: Basic and Clinical Aspects, J. F. Woessner, Jr., D. S. Howell. Marcel Dekker, Inc, New York 1993; 281–345
   Google Scholar
• Westacott C., Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction?. Sem. Arthritis Rheum. 1996; 25: 254–272
   PubMed Web of Science ®Google Scholar
• Fell H., Jubb R. W. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum. 1977; 20: 1359–1371
   PubMed Web of Science ®Google Scholar
• Dingle J. T., Saklatvala J., Hembry R., Tyler J., Fell H., Jubb R. A cartilage catabolic factor from synovium. Biochem. J. 1979; 184: 177–180
   PubMed Web of Science ®Google Scholar
• Dayer J., Russell R., Krane S. M. Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science 1977; 195: 181–183
   PubMed Web of Science ®Google Scholar
• Meats J. E., Guire M., Russell R. G. Human synovium releases a factor which stimulates chondrocyte production of PGE and plasminogen activator. Nature 1980; 286: 891–892
   PubMed Web of Science ®Google Scholar
• Saklatvala J., Pilsworth L. M., Sarsfield S. J., Gavrilovic J., Heath J. K. Pig catabolin is a form of interleukin 1. Cartilage and bone resorb. fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem. J. 1984; 224: 461–466
   PubMed Web of Science ®Google Scholar
• Radin E. L., Burr D. B., Caterson B., Fyhrie D., Brown T., Boyd R. D. Mechanical determinants of osteoarthrosis. Sem. Arthritis Rheum. 1991; 21: 12–21
   PubMed Web of Science ®Google Scholar
• Moskowitz R. W., Davis W., Sammarco J., Martens M., Baker J., Mayor M., Burstein A., Frankel V. H. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum. 1973; 16: 397–405
   PubMed Web of Science ®Google Scholar
• Myers S. L., Brandt K. D., Connor B. L., Visco D., Albrecht M. E. Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection. Effect of surgical hemostasis. Arthritis Rheum. 1990; 33: 1406–1415
   PubMed Web of Science ®Google Scholar
• Pickvance E. A., Oegema T. R., Thompson R. C. Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J. Orthop. Res. 1993; 11: 313–323
   PubMed Web of Science ®Google Scholar
• Pelletier J. P., Faure M. P., Battista J. A., Wilhelm S., Visco D., Martel-Pelletier J. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am. J. Pathol 1993; 142: 95–105
   PubMed Web of Science ®Google Scholar
• Mehraban F., Kuo S. Y., Riera H., Chang C., Moskowitz R. W. Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum. 1994; 37: 1189–1197
   PubMed Web of Science ®Google Scholar
• Mehraban F., Tindal M. H., Proffitt M., Moskowitz R. W. Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: gene expression in chondrocytes in response to interleukin-1 and matrix depiction. Ann. Rheum. Dis. 1997; 56: 108–115
   PubMed Web of Science ®Google Scholar
• Fernandes J. C., Caron J. P., Pelletier J., Jovanovic D., Mineau F., Tardif G., Otterness I., Pelletier J. Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity. Arthritis Rheum. 1997; 40: 284–294
   PubMed Web of Science ®Google Scholar
• Arend W., Dayer J. Inhibition of the produciton and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum. 1995; 38: 151–160
   PubMed Web of Science ®Google Scholar
• Caron J. P., Fernandes J. C., Martel-Pelletier J., Tardif G., Mineau F., Geng C., Pelletier J. Chondro-protective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 1996; 39: 1535–1544
   PubMed Web of Science ®Google Scholar
• Pettipher E. R., Higgs G., Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA 1986; 83: 8749–8753
   PubMed Web of Science ®Google Scholar
• O'Byrne E., Blancuzzi V., Wilson D. E., Wong M., Jeng A. Y. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum. 1990; 33: 1023–1028
   PubMed Web of Science ®Google Scholar
• vanBeuningen H. M., Arntz O., Berg W. B. In vivo effects of interleukin-1 on articular cartilage. Arthritis Rheum. 1991; 34: 606–615
   PubMed Web of Science ®Google Scholar
• Henderson B., Pettipher E. R. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor alpha in the rabbit: evidence for synergic interactions between cytokines in vivo. Clin. Exp. Immunol. 1989; 75: 306–310
   PubMed Web of Science ®Google Scholar
• Thomas D. P., King B., Dingle J. T. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann. Rheum. Dis. 1991; 50: 75–80
   PubMed Web of Science ®Google Scholar
• van deLoo F. A., Joosten L. A., vanLent P. L., Arntz O., Berg W. B. Role of interleukin-1, tumor necrosis factor o, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 1995; 38: 164–172
   PubMed Web of Science ®Google Scholar
• Joosten L. A., Helsen M. M., Loo F., Berg W. B. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF a, anti-IL-1 ajil, and IL-lRa. Arthritis Rheum. 1996; 39: 797–809
   PubMed Web of Science ®Google Scholar
• Kammermann J. R., Kincaid S. A., Rumph P. F., Baird D., Visco D. M. Tumor necrosis factor-a (TNF-Q) in canine osteoarthritis: Immunolocalization of TNF-Q, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis and Cartilage 1996; 4: 23–34
   PubMed Web of Science ®Google Scholar
• Webb G. R., Westacott C., Elson C. J. Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis & Cartilage 1997; 5: 427–437
   PubMed Web of Science ®Google Scholar
• Venn G., Nietfeld J. J., Duits A. J., Brennan F. M., Arner E., Covington M., Billingham M., Hardingham T. E. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum. 1993; 36: 819–826
   PubMed Web of Science ®Google Scholar
• Hay C. W., Chu Q., Budsberg S. C., Clayton M., Johnson K. A. Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. Am. J. Vet. Res. 1997; 58: 1027–1032
   PubMed Web of Science ®Google Scholar
• Maini R. N., Elliott M. J., Brennan F., Feldmann M. Beneficial effects of tumour necrosis factor-alpha (TNF-a) blockade in rheumatoid arthritis (RA). Clin. Exp. Immunol 1995; 101: 207–212
   PubMed Web of Science ®Google Scholar
• Symons C., Wong W. L., Palladino M., Duff G. W. Interleukin-8 in rheumatoid and osteoarthritis. Scand. J. Rheumatol 1992; 21: 92–94
   PubMed Web of Science ®Google Scholar
• Lotz M., Bober L., Narula S., Dudler J. IL-17 promotes cartilage degradation. Arthritis Rheum. 1996; 39: S120
   Google Scholar
• Joosten L. A., Lubberts E., Durez P., Helsen M. M., Jacobs M. J., Goldman M., van denBerg W. B. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 1997; 40: 249–260
   PubMed Web of Science ®Google Scholar
• Alaaeddine N., Battista J., Pelletier J., Kiansa K., Martel-Pelletier J. Inhibition of TNF-a-induced PGE2 production by the antiinflammatory cytokines IL-4, IL-10 and IL-13 on osteoarthritic (OA) synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis Rheum 1997; 40: S39
   Google Scholar
• vanBeuningen H. M., Kraan P. M., Arntz O., Berg W. B. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-β1: age-related differences. Ann. Rheum. Dis. 1994; 53: 593–600
   PubMed Web of Science ®Google Scholar
• vanBeuningen H., Kraan P. M., Arntz O., Berg W. B. Transforming growth factor-β1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 1994; 71: 279–290
   PubMed Web of Science ®Google Scholar
• Elford P. R., Graeber M., Ohtsu H., Aeberhard M., Legendre B., Wishart W., Kenzie A. R. Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor β-2 in the rabbit. Cytokine 1992; 4: 232–238
   PubMed Web of Science ®Google Scholar
• Sellers R. S., Peluso D., Morris E. A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J. Bone Joint Surg. 1997; 79A: 1452–1463
   Web of Science ®Google Scholar
• Glansbeek H. L., Beuningen H. M., Vitters E. L., Morris E. A., Kraan P., Berg W. B. Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1 α effects on proteoglycan synthesis and content. Arthritis Rheum. 1997; 40: 1020–1028
   PubMed Web of Science ®Google Scholar
• Rogachefsky R. A., Dean D. D., Howell D., Altman R. D. Treatment of canine osteoarthritis with insulinlike growth factor-1 (IGF-1) and sodium pentosan poly-sulfate. Osteoarthritis and Cartilage 1993; 1: 105–114
   PubMedGoogle Scholar
• Chrisman O. D., Fessel J., Southwich W. O. Experimental production of synovitis and marginal articular exostoses in the knee joint of dogs. Yale J. Biol. Med. 1965; 37: 409–412
   PubMed Web of Science ®Google Scholar
• Evans C. H., Mazzocchi R. A., Nelson D., Rubash H. E. Experimental arthritis induced by intraarticular injection of allogenic cartilaginous particles into rabbit knees. Arthritis &Rheumatism 1984; 27: 200–207
   PubMed Web of Science ®Google Scholar
• Boniface R. J., Cain P., Evans C. H. Articular responses to purified cartilage proteoglycans. Arthritis &Rheumatism 1988; 31: 258–266
   PubMed Web of Science ®Google Scholar
• Poole A. R. Immunology of cartilage. Osteoarthritis Diagnosis and Management, R. W. Moskowitz, D. S. Howell, V. M. Goldberg, H. J. Mankin. WB Saunders, Philadelphia 1991; 155–189
   Google Scholar
• Trentham D. E., Townes A., Kang A. H. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 1977; 146: 857–868
   PubMed Web of Science ®Google Scholar
• Courtenay J. S., Dallman M. J., Dayan A. D., Martin A., Mosedale B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980; 282: 666–668
   Google Scholar
• Giant T. T. Induction of cartilage degradation in experimental arthritis produced by allogeneic and xenogeneic proteoglycan antigens. Conn. Tiss. Res. 1982; 9: 137–144
   PubMed Web of Science ®Google Scholar
• Champion B., Poole A. R. Immunity to homologous cartilage proteoglycans in rabbits with chronic inflammatory arthritis. Collagen Rel Res. 1981; 1: 453–473
   PubMedGoogle Scholar
• Dayer E., Mathai L., Giant T. T., Mikecz K., Poole A. R. Cartilage proteoglycan-induced arthritis in BALB/c mice. Antibodies that recognize human and mouse cartilage proteoglycan and can cause depletion of cartilage proteoglycan with little or no synovitis. Arthritis Rheum. 1990; 33: 1394–1405
   PubMed Web of Science ®Google Scholar
• Buzas E. I., Brennan F. R., Mikecz K., Garzo M., Negroiu G., Hollo K., Cs-Szabo G., Pintye E., Giant T. T. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J. Immunol 1995; 155: 2679–2687
   PubMed Web of Science ®Google Scholar
• Giant T. T., Szabo G., Oxto J. M., Mativi Y., Mikecz K. Autoimmune progressive polyarthritis induced by aggrecan human osteoarthritic cartilage. Osteoarthritis and Cartilage 1997; 5(Suppl. A)33
   Google Scholar
• Homandberg G. A., Meyers R., Williams J. M. Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo. J. Rheumatol 1993; 20: 1378–1382
   PubMed Web of Science ®Google Scholar
• Xie D. L., Meyers R., Homandberg G. A. Fibronectin fragments in osteoarthritic synovial fluid. J. Rheumatol 1992; 19: 1448–1452
   PubMed Web of Science ®Google Scholar
• Homandberg G. A., Meyers R., Xie D. L. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J. Biol. Chem. 1992; 267: 3597–3604
   PubMed Web of Science ®Google Scholar
• Xie D. L., Hui F., Meyers R., Homandberg G. A. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch. Biochem. Biophys. 1994; 311: 205–212
   PubMed Web of Science ®Google Scholar
• Homandberg G. A., Hui F., Wen C., Purple C., Bewsey K., Koepp H., Huch K., Harris A. Fibro-nectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem. J. 1997; 321: 751–757
   PubMed Web of Science ®Google Scholar
• Homandberg G. A., Davis G., Maniglia C., Shrikhande A. Cartilage chondrolysis by fibronectin fragments causes cleavage of aggrecan at the same site as found in osteoarthritic cartilage. Osteoarthritis &Cartilage 1997; 5: 450–453
   PubMed Web of Science ®Google Scholar
• Zheng H., Fletcher D., Kozak W., Jiang M., Hofmann K. J., Conn C. A., Soszynski D., Grabiec C., Trumbauer M. E., Shaw A., Kostura M. J., Stevens K., Rosen H., North R. J., Chen H. Y., Tocci M. J., Kluger M., Ploeg L. H.T. Resistance to fever induction and impaired acute-phase response in interleukin-1 β-deficient mice. Immunity 1995; 3: 9–19
   PubMed Web of Science ®Google Scholar
• Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., McDowell J., Paskind M., Rodman L., Salfeld J., et al. Mice deficient in IL-1β-convertmg enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995; 80: 401–411
   PubMed Web of Science ®Google Scholar
• Ku G., Fausl T., Lauffer L. L., Livingston D., Harding M. W. Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 1996; 8: 377–386
   PubMed Web of Science ®Google Scholar
• Hirsch E., Irikura V. M., Paul S., Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Nail. Acad. Sci. USA 1996; 93: 11008–11013
   PubMed Web of Science ®Google Scholar
• Mudgett J. S., Hutchinson N. I., Chartrain N. A., Forsyth A. J., McDonnell J., Singer I. I., Bayne E. K., Flanagan J., Dawka D., Shen C. F., Stevens K., Chen H., Trumbauer M., Visco D. M. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 1998; 41: 110–121
   PubMed Web of Science ®Google Scholar
• Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive model of arthritis. EMBO J. 1991; 10: 4025–4031
   PubMed Web of Science ®Google Scholar
• Butler D. M., Malfait A., Mason L. J., Warden P. J., Kollias G., Maim R. N., Feldmann M., Brennan F. M. DBA/Imice expressing the human TNF-α transgene develop a severe, erosive arthritis. Characterization of the cytokine cascade and cellular composition. J. Immunol. 1997; 159: 2867–2876
   PubMed Web of Science ®Google Scholar
• van deLoo F., Kuiper S., van Enckevort F., Arntz O., Berg W. B. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am. J. Path. 1997; 151: 177–191
   PubMed Web of Science ®Google Scholar
• Loo F. A., Arntz O. V., Berg W. B. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis. Cytokine. 1997; 9: 453–462
   PubMed Web of Science ®Google Scholar
• Mundlos S., Olsen B. R. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J. 1997; 11: 125–132
   PubMed Web of Science ®Google Scholar
• Mundlos S., Olsen B. R. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J. 1997; 11: 227–233
   PubMed Web of Science ®Google Scholar
• Bleasel J. F., Faure A., Holderbaum D., Vacher-Lavenu M. C., Haqqi T. M., Moskowitz R., Menkes C. J. Type II procollagen gene (COL2A1) mutation in exon II associated with spondyloepiphyseal dysplasia, tall stature and precocious osteoarthritis. J. Rheumatol. 1995; 22: 255–261
   PubMed Web of Science ®Google Scholar
• Bleasel J. F., Holderbaum D., Haqqi T., Moskowitz R. W. Clinical correlations of osteoarthritis associated with single base mutations in the type II procollagen gene. J. Rheumatol. 1995; 43(Suppl.)34–36
   Google Scholar
• Bleasel J. F., Holderbaum D., Mallock V., Haqqi T. M., Williams H., Moskowitz R. W. Hereditary osteoarthritis with mild spondyloepiphyseal dysplasia are there “hot spots” on COL2A. V.J. Rheumatol. 1996; 23: 1594–1598
   PubMed Web of Science ®Google Scholar
• deCrombrugghe B., Katzenstein P., Mukhopadhyay K., Lefebvre V., Zhou G., Garofalo S., Metsaranta M., Rosati R., Vuorio E. Transgenic mice with deficiencies in cartilage collagens: possible models for gene therapy. J. Rheumatol. 1995; 43(Suppl.)140–42
   Google Scholar
• Li Y., Lacerda D. A., Wurman M. L., Beier D. R., Yoshioka H., Ninomiya Y., Oxford J. T., Morris N. P., Andrikopoulos K., Ramirez F., et al. A fibrillar collagen gene. Colllal, is essential for skeletal morphogenesis. Cell. 1995; 80: 423–430
   PubMed Web of Science ®Google Scholar
• Li Y., Olsen B. R. Murine models of human genetic skeletal disorders. Matrix Biol. 1997; 16: 49–52
   PubMed Web of Science ®Google Scholar
• Vikkula M., Mariman E. C., Lui V. C., Zhidkova N. I., Tiller G. E., Goldring M. B., Beersum S. E., Malefijt M. C., van den Hoogen F. H., Ropers H. H., et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995; 80: 431–437
   PubMed Web of Science ®Google Scholar
• Vertel B. M. The ins and outs of aggrecan. Trends Cell Biol. 1995; 5: 458–464
   PubMed Web of Science ®Google Scholar
• Jacenko O., Ito S., Olsen B. R. Skeletal and hematopoietic defects in mice transgenic for collagen X. Ann. N. Y. Acad. Sci. 1996; 785: 278–280
   PubMed Web of Science ®Google Scholar
• Schnieke A. E., Kind A. J., Ritchie W. A., Mycock K., Scott A. R., Ritchie M., Wilmut I., Colman A., Campbell K. H.S. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 1997; 278: 2130–2133
   PubMed Web of Science ®Google Scholar
• Bandara G., Mueller G. M., Lauri J., Tindal M. H., Georgescu H. I., Suchanek M. K., Hung G. L., Glorioso J. C., Robbins P., Evans C. H. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA 1993; 90: 10764–10768
   PubMed Web of Science ®Google Scholar
• Evans C. H., Robbins P. D., Ghivizzani S. C., Herndon J. H., Kang R., Bahnson A. B., Barranger J. A., Elders E. M., Gay S., Tomaino M. M., Wasko M. C., Watkins S. C., Whiteside T. L., Glorioso J. C., Lotze M., Wright T. M. Clinical trial to assess the safetyfeasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Human Gene Therapy 1996; 7: 1261–1280
   PubMed Web of Science ®Google Scholar
• Ghivizzani S. C., Lechman E. R., Kang R., Tio C., Kolls J., Evans C., Robbins P. D. Direct adeno-virus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Nat. Acad. Sci. of the USA 1998; 95: 4613–4618
   PubMed Web of Science ®Google Scholar
• Whalen J. D., Lechman E., Robbins P., Evans C. H. Gene transfer of the viral IL-10 gene to the mouse footpad can prevent collagen-type II induced arthritis. Trans. Orthop. Res. Soc 1998; 23: 308
   Google Scholar
• Baragi V. M., Renkiewicz R. R., Jordan H., Bonadio J., Hartman J., Roessler B. J. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J. Clin. Invest. 1995; 96: 2454–2460
   PubMed Web of Science ®Google Scholar
• Muller-Ladner U., Roberts C. R., Franklin B. N., Gay R. E., Robbins P. D., Evans C., Gay S. Human IL-IRa gene transfer into human synovial fibroblasts is chondroprotcctive. J. Immunol. 1997; 158: 3492–3498
   PubMed Web of Science ®Google Scholar
• Pelletier J., Caron J. P., Evans C., Robbins P. D., Georgescu H. I., Jovanovic D., Fernandes J., Pelletier J. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 1997; 40: 1012–1019
   PubMed Web of Science ®Google Scholar
• Ghivizzani S. C., Nita I. M., Georgescu H. I., Suh J. K., Robbins P., Evans C. H. Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis &Cartilage. 1997; 5: 139–143
   PubMed Web of Science ®Google Scholar